Skip to main content
Erschienen in: Applied Health Economics and Health Policy 3/2004

01.09.2004 | Article

Examining within-country variation of maternity costs in the context of a multicountry, multicentre randomised controlled trial

verfasst von: Dr Guy Hutton, Julia Fox-Rushby, Miranda Mugford, Jadsada Thinkhamrop, Bandit Thinkhamrop, Ana Maria Galvez, Manuel Alvarez

Erschienen in: Applied Health Economics and Health Policy | Ausgabe 3/2004

Einloggen, um Zugang zu erhalten

Abstract

Understanding why healthcare costs vary between patients and between health facilities is important in guiding health policy decisions as well as in research. However, there is no comprehensive framework that analysts commonly use for expressing and examining causes of cost variation in the field of healthcare. The aim of this study is to better understand the size and causes of within-country healthcare cost variation, through presenting evidence for size and sources of such variations for two countries (Cuba and Thailand) in the context of a randomised controlled trial on antenatal care. The article separates total costs into their two components: unit costs and health service use. Unit costs are further separated into input quantity per patient visit or day, and the prices of these resources. The results show that the main determinant of average cost is the staffing pattern and productivity, whereas the main determinants of health service use include the model of antenatal care being practised and the risk status and illnesses suffered by patients. However, variations in inpatient health service use between facilities are largely related to unexplainable variations in practice between facilities, irrespective of the trial arm. In conclusion, cost variations have important implications for the design of clinical trials and for policy makers using evidence from trials in planning health services and budgets.
Literatur
1.
Zurück zum Zitat Spath HM, Carrere MO, Fervers B, et al. Analysis of the eligibility of published economic evaluations for transfer to a given health care system: methodological approach and application to the French health care system. Health Policy 1999: 49: 161–77PubMedCrossRef Spath HM, Carrere MO, Fervers B, et al. Analysis of the eligibility of published economic evaluations for transfer to a given health care system: methodological approach and application to the French health care system. Health Policy 1999: 49: 161–77PubMedCrossRef
2.
Zurück zum Zitat Madden L, Hussey R, Mooney G, et al. Public health and economics in tandem: programme budgeting, marginal analysis and priority setting in practice. Health Policy 1995; 33: 161–8PubMedCrossRef Madden L, Hussey R, Mooney G, et al. Public health and economics in tandem: programme budgeting, marginal analysis and priority setting in practice. Health Policy 1995; 33: 161–8PubMedCrossRef
3.
Zurück zum Zitat Drummond MF, Bloom BS, Carrin G, et al. Issues in the cross-national assessment of health technology. Int J Technol Assess Health Care 1992; 8: 671–82PubMedCrossRef Drummond MF, Bloom BS, Carrin G, et al. Issues in the cross-national assessment of health technology. Int J Technol Assess Health Care 1992; 8: 671–82PubMedCrossRef
4.
Zurück zum Zitat Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 1994; 3: 95–104PubMedCrossRef Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 1994; 3: 95–104PubMedCrossRef
5.
Zurück zum Zitat Jefferson T, Mugford M, Graym A, et al. An exercise on the feasibility of carrying out secondary economic analyses. Health Econ 1996; 5: 155–65PubMedCrossRef Jefferson T, Mugford M, Graym A, et al. An exercise on the feasibility of carrying out secondary economic analyses. Health Econ 1996; 5: 155–65PubMedCrossRef
6.
Zurück zum Zitat O’Brien B. A tale of two (or more) cities: geographical transferability of pharmacoeconomic data. Am J Manag Care 1997; 3 Suppl.: S33-9 O’Brien B. A tale of two (or more) cities: geographical transferability of pharmacoeconomic data. Am J Manag Care 1997; 3 Suppl.: S33-9
7.
Zurück zum Zitat Bryan S, Brown J. Extrapolation of cost-effectiveness information to local settings. J Health Serv Res Policy 1998; 3: 108–12PubMed Bryan S, Brown J. Extrapolation of cost-effectiveness information to local settings. J Health Serv Res Policy 1998; 3: 108–12PubMed
8.
Zurück zum Zitat Udvarhelyi IS, Colditz GA, Rai A, et al. Cost-effectiveness and cost-benefit analyses in the medical literature: are the methods being used correctly? Ann Intern Med 1992; 116: 238–44PubMed Udvarhelyi IS, Colditz GA, Rai A, et al. Cost-effectiveness and cost-benefit analyses in the medical literature: are the methods being used correctly? Ann Intern Med 1992; 116: 238–44PubMed
9.
10.
11.
Zurück zum Zitat Walker D, Fox-Rushby JA. Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature. Health Econ 2000; 9: 681–98PubMedCrossRef Walker D, Fox-Rushby JA. Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature. Health Econ 2000; 9: 681–98PubMedCrossRef
12.
Zurück zum Zitat Buxton MJ, Drummond MF, Van Hout BA, et al. Modelling in economic evaluation: an unavoidable fact of life. Health Econ 1997; 6: 217–27PubMedCrossRef Buxton MJ, Drummond MF, Van Hout BA, et al. Modelling in economic evaluation: an unavoidable fact of life. Health Econ 1997; 6: 217–27PubMedCrossRef
13.
Zurück zum Zitat Heyse J, Cook J, Carides G. Statistical considerations in analysing health care resource utilization and cost data. In: McGuire A, Drummond M, editors. Economic evaluation in health care: merging theory with practice. New York: Oxford University Press, 2001 Heyse J, Cook J, Carides G. Statistical considerations in analysing health care resource utilization and cost data. In: McGuire A, Drummond M, editors. Economic evaluation in health care: merging theory with practice. New York: Oxford University Press, 2001
14.
Zurück zum Zitat Brouwer W, Rutten F, Koopmanschap M. Costing in economic evaluations. In: McGuire A, Drummond M, editors. Economic evaluation in health care: merging theory with practice. New York: Oxford University Press, 2001 Brouwer W, Rutten F, Koopmanschap M. Costing in economic evaluations. In: McGuire A, Drummond M, editors. Economic evaluation in health care: merging theory with practice. New York: Oxford University Press, 2001
15.
Zurück zum Zitat Drummond M, Pang F. Transferability of economic evaluation results. In: McGuire A, Drummond M, editors. Economic evaluation in health care: merging theory with practice. New York: Oxford University Press, 2001 Drummond M, Pang F. Transferability of economic evaluation results. In: McGuire A, Drummond M, editors. Economic evaluation in health care: merging theory with practice. New York: Oxford University Press, 2001
16.
Zurück zum Zitat De Jonghe E, Murray C, Chum H, et al. Cost-effectiveness of chemotherapy for sputum smear-positive pulmonary tuberculosis in Malawi, Mozambique and Tanzania. Int J Health Plann Manage 1994; 9: 151–81PubMedCrossRef De Jonghe E, Murray C, Chum H, et al. Cost-effectiveness of chemotherapy for sputum smear-positive pulmonary tuberculosis in Malawi, Mozambique and Tanzania. Int J Health Plann Manage 1994; 9: 151–81PubMedCrossRef
17.
Zurück zum Zitat Schulman K, Buxton M, Glick H, et al. Results of the economic evaluation of the FIRST study: a multinational prospective economic evaluation. FIRST Investigators: Flolan International Randomized Survival Trial. Int J Technol Assess Health Care 1996; 12: 698–713PubMedCrossRef Schulman K, Buxton M, Glick H, et al. Results of the economic evaluation of the FIRST study: a multinational prospective economic evaluation. FIRST Investigators: Flolan International Randomized Survival Trial. Int J Technol Assess Health Care 1996; 12: 698–713PubMedCrossRef
18.
Zurück zum Zitat Menzin J, Oster G, Davies L, et al. A multinational economic evaluation of rhDNase in the treatment of cystic fibrosis. Int J Technol Assess Health Care 1996; 12: 52–61PubMedCrossRef Menzin J, Oster G, Davies L, et al. A multinational economic evaluation of rhDNase in the treatment of cystic fibrosis. Int J Technol Assess Health Care 1996; 12: 52–61PubMedCrossRef
19.
Zurück zum Zitat Villar J, Ba’aqeel H, Piaggio G, et al. WHO antenatal care randomised controled trial for the evaluation of a new model of routine antenatal care trial. Lancet 2001; 357: 1551–64PubMedCrossRef Villar J, Ba’aqeel H, Piaggio G, et al. WHO antenatal care randomised controled trial for the evaluation of a new model of routine antenatal care trial. Lancet 2001; 357: 1551–64PubMedCrossRef
20.
Zurück zum Zitat Schulman K, Burke J, Drummond M, et al. Resource costing for multinational neurologic clinical trials: methods and results. Health Econ 1998; 7: 629–38PubMedCrossRef Schulman K, Burke J, Drummond M, et al. Resource costing for multinational neurologic clinical trials: methods and results. Health Econ 1998; 7: 629–38PubMedCrossRef
21.
Zurück zum Zitat Jonsson B, Johannesson M, Kjekshus J, et al. Cost-effectiveness of cholesterol lowering: results from the Scandinavian simvastatin survival study (4S). Eur Heart J 1996; 17: 1001–7PubMedCrossRef Jonsson B, Johannesson M, Kjekshus J, et al. Cost-effectiveness of cholesterol lowering: results from the Scandinavian simvastatin survival study (4S). Eur Heart J 1996; 17: 1001–7PubMedCrossRef
22.
Zurück zum Zitat Glick H, Willke R, Polsky D, et al. Economic analysis of Tirilazad Mesylate for aneurysmal subarachnoid hemorrhage. Int J Health Plann Manage 1998; 14: 145–60 Glick H, Willke R, Polsky D, et al. Economic analysis of Tirilazad Mesylate for aneurysmal subarachnoid hemorrhage. Int J Health Plann Manage 1998; 14: 145–60
23.
Zurück zum Zitat Dasbach E, Rich M, Segal R, et al. The cost-effectiveness of losartan versus captopril in patients with symptomatic heart failure. Cardiology 1999; 91: 189–94PubMedCrossRef Dasbach E, Rich M, Segal R, et al. The cost-effectiveness of losartan versus captopril in patients with symptomatic heart failure. Cardiology 1999; 91: 189–94PubMedCrossRef
24.
Zurück zum Zitat Jonsson B, Weinstein M. Economic evaluation alongside multinational trials: study considerations for GUSTO IIb. Int J Technol Assess Health Care 1997; 13: 49–58PubMedCrossRef Jonsson B, Weinstein M. Economic evaluation alongside multinational trials: study considerations for GUSTO IIb. Int J Technol Assess Health Care 1997; 13: 49–58PubMedCrossRef
25.
Zurück zum Zitat Wimo A, Winblad B, Engedal K, et al. An economic evaluation of donepezil in mild to moderate Alzheimer’s disease: results of a 1-year, double-blind, randomized trial. Dement Geriatr Cogn Disord 2003; 15: 44–54PubMedCrossRef Wimo A, Winblad B, Engedal K, et al. An economic evaluation of donepezil in mild to moderate Alzheimer’s disease: results of a 1-year, double-blind, randomized trial. Dement Geriatr Cogn Disord 2003; 15: 44–54PubMedCrossRef
26.
Zurück zum Zitat Lumbiganon P, Bergso P, Ba’aqeel H, et al., editors. A randomised controlled trial for the evaluation of a new antenatal care model. Paediatr Perinat Epidemiol 1998; 12 Suppl. 2: 1–164 Lumbiganon P, Bergso P, Ba’aqeel H, et al., editors. A randomised controlled trial for the evaluation of a new antenatal care model. Paediatr Perinat Epidemiol 1998; 12 Suppl. 2: 1–164
27.
Zurück zum Zitat Mugford M, Hutton G, Fox-Rushby J. Methods for the economic evaluation alongside a multicentre trial in developing countries: a case study from the WHO antenatal care randomised controlled trial. Paediatr Perinat Epidemiol 1998; 12: 75–97PubMedCrossRef Mugford M, Hutton G, Fox-Rushby J. Methods for the economic evaluation alongside a multicentre trial in developing countries: a case study from the WHO antenatal care randomised controlled trial. Paediatr Perinat Epidemiol 1998; 12: 75–97PubMedCrossRef
28.
Zurück zum Zitat Donaldson C. The state of the art of costing health care for economic evaluation. Community Health Stud 1990; 14: 341–56PubMedCrossRef Donaldson C. The state of the art of costing health care for economic evaluation. Community Health Stud 1990; 14: 341–56PubMedCrossRef
29.
Zurück zum Zitat Rovira J. Standardising economic appraisal of health technology in the European Community. Soc Sci Med 1994; 38: 1675–8PubMedCrossRef Rovira J. Standardising economic appraisal of health technology in the European Community. Soc Sci Med 1994; 38: 1675–8PubMedCrossRef
30.
Zurück zum Zitat Baladi J-F. A guidance process for the costing process. Ottawa: Canadian Coordinating Office for Health Technology Assessment, 1996 Baladi J-F. A guidance process for the costing process. Ottawa: Canadian Coordinating Office for Health Technology Assessment, 1996
31.
Zurück zum Zitat Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996 Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996
32.
Zurück zum Zitat Drummond MF, O’Brien B, Stoddart GL, et al. Methods for the economic evaluation of health care programmes. New York: Oxford University Press, 1997 Drummond MF, O’Brien B, Stoddart GL, et al. Methods for the economic evaluation of health care programmes. New York: Oxford University Press, 1997
33.
Zurück zum Zitat Galvez A, Alvarez M, Sanabria G, et al. Economic evaluation alongside an antenatal care trial in developing countries. Report on Cuba [research report no. 12]. Norwich: School of Health Policy and Practice, University of East Anglia, 2000 Galvez A, Alvarez M, Sanabria G, et al. Economic evaluation alongside an antenatal care trial in developing countries. Report on Cuba [research report no. 12]. Norwich: School of Health Policy and Practice, University of East Anglia, 2000
34.
Zurück zum Zitat Thinkhamrop J, Thinkhamrop B, Kuchaisit C, et al. A study on the costs of antenatal care alongside the World Health Organization trial in Thailand [research report no. 10]. Norwich: School of Health Policy and Practice, University of East Anglia, 2000 Thinkhamrop J, Thinkhamrop B, Kuchaisit C, et al. A study on the costs of antenatal care alongside the World Health Organization trial in Thailand [research report no. 10]. Norwich: School of Health Policy and Practice, University of East Anglia, 2000
35.
Zurück zum Zitat Borghi J, Bastus S, Belizan M, et al. Costs of antenatal and related care in Argentina: a cost-minimisation analysis of the new WHO antenatal care package. London: London School of Hygiene and Tropical Medicine, 2000 Borghi J, Bastus S, Belizan M, et al. Costs of antenatal and related care in Argentina: a cost-minimisation analysis of the new WHO antenatal care package. London: London School of Hygiene and Tropical Medicine, 2000
36.
Zurück zum Zitat Smith S, Fox-Rushby J, Hutton G, et al. An economic evaluation of the costs of the new WHO programme of antenatal care in Saudi Arabia. London: London School of Hygiene and Tropical Medicine, 2001 Smith S, Fox-Rushby J, Hutton G, et al. An economic evaluation of the costs of the new WHO programme of antenatal care in Saudi Arabia. London: London School of Hygiene and Tropical Medicine, 2001
37.
Zurück zum Zitat Langer A, Villar J, Romero M, et al. Are women and providers satisfied with antenatal care? Views on a standard and a simplified, evidence-based model of care in four developing countries. BMC Womens Health 2002; 2: 7–16PubMedCrossRef Langer A, Villar J, Romero M, et al. Are women and providers satisfied with antenatal care? Views on a standard and a simplified, evidence-based model of care in four developing countries. BMC Womens Health 2002; 2: 7–16PubMedCrossRef
38.
Zurück zum Zitat Langer A, Nigenda G. Conceptual basis and methodology for the evaluation of women’s and providers’ perception of the quality of antenatal care in the WHO antenatal care randomised controlled trial. Paediatr Perinat Epidemiol 1998; 12: 98–115PubMedCrossRef Langer A, Nigenda G. Conceptual basis and methodology for the evaluation of women’s and providers’ perception of the quality of antenatal care in the WHO antenatal care randomised controlled trial. Paediatr Perinat Epidemiol 1998; 12: 98–115PubMedCrossRef
Metadaten
Titel
Examining within-country variation of maternity costs in the context of a multicountry, multicentre randomised controlled trial
verfasst von
Dr Guy Hutton
Julia Fox-Rushby
Miranda Mugford
Jadsada Thinkhamrop
Bandit Thinkhamrop
Ana Maria Galvez
Manuel Alvarez
Publikationsdatum
01.09.2004
Verlag
Springer International Publishing
Erschienen in
Applied Health Economics and Health Policy / Ausgabe 3/2004
Print ISSN: 1175-5652
Elektronische ISSN: 1179-1896
DOI
https://doi.org/10.2165/00148365-200403030-00007

Weitere Artikel der Ausgabe 3/2004

Applied Health Economics and Health Policy 3/2004 Zur Ausgabe